| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/31/2023 | — | BMO Capital | Upgrades | Market Perform → Outperform | |
| 08/15/2023 | 13.21% | Keefe, Bruyette & Woods | $124 → $120 | Maintains | Market Perform |
| 07/12/2023 | 50.94% | JMP Securities | $170 → $160 | Maintains | Market Outperform |
| 07/06/2023 | 44.34% | Piper Sandler | $155 → $153 | Upgrades | Neutral → Overweight |
| 05/18/2023 | 22.64% | B of A Securities | → $130 | Downgrades | Buy → Neutral |
| 04/18/2023 | 33.02% | Keefe, Bruyette & Woods | $148 → $141 | Maintains | Market Perform |
| 04/18/2023 | 60.38% | JMP Securities | → $170 | Reiterates | → Market Outperform |
| 04/04/2023 | 50% | Piper Sandler | $153 → $159 | Maintains | Neutral |
| 02/06/2023 | 39.62% | Keefe, Bruyette & Woods | $142 → $148 | Maintains | Market Perform |
| 02/03/2023 | 60.38% | JMP Securities | → $170 | Reiterates | → Market Outperform |
| 01/20/2023 | 33.02% | BMO Capital | → $141 | Initiates Coverage On | → Market Perform |
| 11/22/2022 | 41.51% | Morgan Stanley | $145 → $150 | Maintains | Equal-Weight |
| 11/11/2022 | 54.72% | Janney Montgomery Scott | → $164 | Initiates Coverage On | → Buy |
| 11/07/2022 | 35.85% | Piper Sandler | → $144 | Downgrades | Overweight → Neutral |
| 08/19/2022 | 36.79% | Morgan Stanley | $155 → $145 | Maintains | Equal-Weight |
| 06/29/2022 | 46.23% | Morgan Stanley | → $155 | Initiates Coverage On | → Equal-Weight |
| 08/17/2021 | 35.85% | Wolfe Research | → $144 | Initiates Coverage On | → Peer Perform |
| 05/21/2021 | 56.6% | B of A Securities | → $166 | Initiates Coverage On | → Buy |
| 04/16/2021 | 36.79% | JMP Securities | $140 → $145 | Maintains | Market Outperform |
| 09/03/2020 | 10.38% | Credit Suisse | → $117 | Initiates Coverage On | → Neutral |
| 06/03/2020 | 7.55% | Piper Sandler | $110 → $114 | Maintains | Overweight |
| 04/16/2020 | 32.08% | JMP Securities | $150 → $140 | Maintains | Market Outperform |
| 04/06/2020 | -19.81% | Piper Sandler | $130 → $85 | Maintains | Overweight |
| 03/11/2020 | 22.64% | Piper Sandler | $151 → $130 | Maintains | Overweight |
| 01/22/2020 | 36.79% | Buckingham Research | $142 → $145 | Maintains | Buy |
| 03/01/2019 | — | Compass Point | Initiates Coverage On | → Buy | |
| 09/26/2018 | 25.47% | Piper Sandler | $125 → $133 | Upgrades | Neutral → Buy |
What is the target price for Hanover Insurance Gr (THG)?
The latest price target for Hanover Insurance Gr (NYSE: THG) was reported by BMO Capital on August 31, 2023. The analyst firm set a price target for $0.00 expecting THG to fall to within 12 months (a possible -100.00% downside). 14 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Hanover Insurance Gr (THG)?
The latest analyst rating for Hanover Insurance Gr (NYSE: THG) was provided by BMO Capital, and Hanover Insurance Gr upgraded their outperform rating.
When is the next analyst rating going to be posted or updated for Hanover Insurance Gr (THG)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Hanover Insurance Gr, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Hanover Insurance Gr was filed on August 31, 2023 so you should expect the next rating to be made available sometime around August 31, 2024.
Is the Analyst Rating Hanover Insurance Gr (THG) correct?
While ratings are subjective and will change, the latest Hanover Insurance Gr (THG) rating was a upgraded with a price target of $125.00 to $0.00. The current price Hanover Insurance Gr (THG) is trading at is $106.00, which is out of the analyst's predicted range.